Elanco Animal Health Inc Quarterly Net Income (Loss) Attributable to Parent in USD from Q1 2017 to Q4 2024

Taxonomy & unit
us-gaap: USD
Description
The portion of profit or loss for the period, net of income taxes, which is attributable to the parent.
Summary
Elanco Animal Health Inc quarterly/annual Net Income (Loss) Attributable to Parent history and growth rate from Q1 2017 to Q4 2024.
  • Elanco Animal Health Inc Net Income (Loss) Attributable to Parent for the quarter ending December 31, 2024 was -$8M, a 94.3% increase year-over-year.
  • Elanco Animal Health Inc Net Income (Loss) Attributable to Parent for the twelve months ending December 31, 2024 was $338M.
  • Elanco Animal Health Inc annual Net Income (Loss) Attributable to Parent for 2024 was $338M.
  • Elanco Animal Health Inc annual Net Income (Loss) Attributable to Parent for 2023 was -$1.23B, a 1478% decline from 2022.
  • Elanco Animal Health Inc annual Net Income (Loss) Attributable to Parent for 2022 was -$78M, a 83.9% increase from 2021.
Net Income (Loss) Attributable to Parent, Trailing 12 Months (USD)
Net Income (Loss) Attributable to Parent, Quarterly (USD)
Net Income (Loss) Attributable to Parent, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q4 2024 $338M -$8M +$133M +94.3% Oct 1, 2024 Dec 31, 2024 10-K 2025-02-25
Q3 2024 $205M $364M +$1.46B Jul 1, 2024 Sep 30, 2024 10-Q 2024-11-07
Q2 2024 -$1.26B -$50M +$47M +48.5% Apr 1, 2024 Jun 30, 2024 10-Q 2024-11-07
Q1 2024 -$1.3B $32M -$71M -68.9% Jan 1, 2024 Mar 31, 2024 10-Q 2024-11-07
Q4 2023 -$1.23B -$141M -$87M -161% Oct 1, 2023 Dec 31, 2023 10-K 2025-02-25
Q3 2023 -$1.14B -$1.1B -$1.03B -1586% Jul 1, 2023 Sep 30, 2023 10-Q 2024-11-07
Q2 2023 -$113M -$97M -$87M -870% Apr 1, 2023 Jun 30, 2023 10-Q 2024-11-07
Q1 2023 -$26M $103M +$52M +102% Jan 1, 2023 Mar 31, 2023 10-Q 2024-11-07
Q4 2022 -$78M -$54M +$51M +48.6% Oct 1, 2022 Dec 31, 2022 10-K 2025-02-25
Q3 2022 -$129M -$65M +$43M +39.8% Jul 1, 2022 Sep 30, 2022 10-Q 2023-11-07
Q2 2022 -$172M -$10M +$196M +95.1% Apr 1, 2022 Jun 30, 2022 10-Q 2023-11-07
Q1 2022 -$368M $51M +$115M Jan 1, 2022 Mar 31, 2022 10-Q 2023-11-07
Q4 2021 -$483M -$105M +$218M +67.5% Oct 1, 2021 Dec 31, 2021 10-K 2023-03-01
Q3 2021 -$701M -$108M +$27M +20% Jul 1, 2021 Sep 30, 2021 10-K 2023-03-01
Q2 2021 -$728M -$206M -$153M -289% Apr 1, 2021 Jun 30, 2021 10-K 2023-03-01
Q1 2021 -$575M -$64M -$15M -30.6% Jan 1, 2021 Mar 31, 2021 10-K 2023-03-01
Q4 2020 -$560M -$323M -$313M -3298% Oct 1, 2020 Dec 31, 2020 10-K 2021-03-01
Q3 2020 -$247M -$135M -$145M -1450% Jul 1, 2020 Sep 30, 2020 10-Q 2021-11-05
Q2 2020 -$102M -$53M -$88.9M -248% Apr 1, 2020 Jun 30, 2020 10-Q 2021-11-05
Q1 2020 -$12.6M -$49M -$80.5M -256% Jan 1, 2020 Mar 31, 2020 10-Q 2021-11-05
Q4 2019 $67.9M -$9.5M -$25.9M -158% Oct 1, 2019 Dec 31, 2019 10-K 2021-03-01
Q3 2019 $93.8M $10M -$50.2M -83.4% Jul 1, 2019 Sep 30, 2019 10-Q 2020-11-06
Q2 2019 $144M $35.9M +$98.7M Apr 1, 2019 Jun 30, 2019 10-Q 2020-11-06
Q1 2019 $45.3M $31.5M -$41.2M -56.7% Jan 1, 2019 Mar 31, 2019 10-Q 2020-11-06
Q4 2018 $86.5M $16.4M +$178M Oct 1, 2018 Dec 31, 2018 10-K 2020-02-28
Q3 2018 -$91.4M $60.2M +$80.9M Jul 1, 2018 Sep 30, 2018 10-K 2020-02-28
Q2 2018 -$172M -$62.8M -$32.6M -108% Apr 1, 2018 Jun 30, 2018 10-K 2020-02-28
Q1 2018 -$140M $72.7M +$171M Jan 1, 2018 Mar 31, 2018 10-K 2020-02-28
Q4 2017 -$311M -$162M Oct 1, 2017 Dec 31, 2017 10-K 2019-02-20
Q3 2017 -$20.7M Jul 1, 2017 Sep 30, 2017 10-K 2019-02-20
Q2 2017 -$30.2M Apr 1, 2017 Jun 30, 2017 10-K 2019-02-20
Q1 2017 -$98.3M Jan 1, 2017 Mar 31, 2017 10-K 2019-02-20
* An asterisk sign (*) next to the value indicates that the value is likely invalid.